US-based medical device technology company HemoSonics has won the Marketing award in the 2025 Medical Device Network Excellence Awards for its impactful engagement while marketing the groundbreaking Quantra Hemostasis System.
The Medical Device Network Excellence Awards celebrate the greatest achievements and innovations in the industry. Powered by the business intelligence of GlobalData, the programme provides a platform to recognise the people and companies that are driving change.
Go deeper with GlobalData
HemoSonics won the award for its exceptional ability to communicate the value of the Quantra Hemostasis System, engage the healthcare community through educational initiatives, and demonstrate thought leadership in blood management, all while achieving significant brand recognition.
Exceptional communication and engagement strategies
HemoSonics has demonstrated exceptional prowess in communicating the value of its Quantra Hemostasis System to healthcare professionals and stakeholders. The company has effectively utilized a variety of communication channels, including targeted marketing campaigns, informative webinars, and engaging social media content, to articulate the benefits of its technology. Detailed case studies were produced to showcase successful implementations of the Quantra system in clinical settings, highlighting how it has improved patient outcomes and reduced unnecessary blood transfusions.
By fostering a deeper understanding of its capabilities among clinicians, HemoSonics has facilitated informed decision-making regarding coagulation therapy. This clarity has positioned HemoSonics as a trusted partner in patient-centered care, as healthcare providers recognize the importance of using advanced technology to tailor treatments to individual patient needs. The company’s commitment to transparency and education has not only enhanced its reputation, but also built strong relationships with healthcare professionals who rely on the Quantra system for critical decision-making.
HemoSonics has also successfully leveraged impactful marketing campaigns that emphasize the importance of personalized medicine. By highlighting how the Quantra Hemostasis System tailors coagulation therapy to meet specific patient needs, the company effectively engages both clinicians and patients. Campaigns that feature testimonials from healthcare providers and patients who have benefited from the system serve to humanize the technology and illustrate its real-world impact. This focus on individualized care resonates deeply within the healthcare community, fostering a culture of informed and compassionate treatment.
Thought leadership and educational outreach
HemoSonics has established itself as a thought leader in the medical devices industry by addressing critical issues in blood management through various platforms, including articles, webinars, and podcasts. The company regularly publishes insightful content that discusses emerging trends in coagulation testing and blood management practices. For example, HemoSonics has hosted webinars featuring industry experts who discuss best practices for implementing point-of-care testing in various clinical environments, thereby positioning itself as a go-to resource for healthcare professionals seeking to enhance their knowledge.
These initiatives provide valuable insights into coagulation therapy and patient care, positioning HemoSonics at the forefront of industry discussions. By engaging with key opinion leaders and participating in relevant conferences, HemoSonics shares its expertise as well as gathers feedback that informs future product development and marketing strategies.
A cornerstone of HemoSonics’ strategy has been its commitment to education and awareness within the healthcare community. Through workshops and informative content, the company actively engages healthcare professionals to promote understanding of its innovative solutions. For instance, HemoSonics has organized hands-on workshops where clinicians can experience the Quantra system firsthand, allowing them to see its capabilities in real-time. This educational outreach enhances knowledge and cultivates a collaborative environment where best practices in blood management can flourish.
Strategic partnerships driving growth
The company’s strategic partnerships and collaborations have played a pivotal role in enhancing its brand visibility and market reach. By aligning with key stakeholders in the healthcare sector, such as hospitals, research institutions, and professional organizations, HemoSonics has expanded its influence and accessibility. These partnerships not only amplify marketing efforts but also facilitate the dissemination of knowledge regarding the benefits of the Quantra Hemostasis System.
For example, collaborations with leading hospitals have enabled HemoSonics to conduct clinical studies that validate the efficacy of its technology. The results from these studies are often shared through peer-reviewed publications and presentations at medical conferences, further establishing HemoSonics as a credible authority in coagulation management.
The company’s innovative marketing strategies have been instrumental in driving growth and establishing itself as a leader in the medical devices sector. By embracing new technologies and marketing channels—such as digital marketing campaigns that utilize search engine optimization (SEO) techniques—HemoSonics has effectively reached its target audience. The company’s website features comprehensive resources, including whitepapers and instructional videos that educate potential customers about the advantages of the Quantra system.
This proactive approach to marketing positions HemoSonics for continued success and expansion. As the company continues to innovate and adapt to changing market dynamics, its strategic focus on communication, education, and partnerships will likely play a crucial role in maintaining its leadership position within the medical devices industry.
“We strive to improve patient outcomes and reduce hospital costs each and every day with the Quantra Hemostasis System. The more hospitals and practitioners who know about and adopt Quantra, the greater our ability to help more people becomes. Marketing, awareness and communications are a key part of our strategy around educating healthcare professionals and expanding access to the Quantra Hemostasis System, thus enabling timelier patient-centered decision-making.”
– Bob Roda, President and CEO, Hemosonics
Company Profile
HemoSonics, LLC is a medical device technology company focused on acute bleeding management, resulting in better patient care and lower overall medical costs. The Quantra Hemostasis Analyzer, HemoSonics’ flagship product, is designed to improve patient outcomes and reduce healthcare costs by providing optimised coagulation information.
The Quantra System’s easy and fast interpretation enables simple, more efficient point-of-care and laboratory bleeding management. Based in Durham, NC, HemoSonics is part of the Stago Group, a leading in vitro diagnostics company dedicated to exploring thrombosis and hemostasis.
Contact Details
Bob Roda
President and CEO
HemoSonics
Links
Website: https://hemosonics.com/
